FGBIP:NASDAQFirst Guaranty Bancshares, Inc. - 6.75% Series A Fixed-Rate Non-Cumulative Perpetual Preferred Stock Analysis
Data as of 2026-06-22 - not real-time
$20.08
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
First Guaranty Bancshares is trading at $20.08, just above its technical support of $20 and below the short‑term resistance of $20.70. The stock sits above its 20‑day and 50‑day SMAs (20.36 and 19.37) and the 200‑day SMA (17.78), indicating a bullish long‑term trend, but the MACD histogram is negative and the MACD signal line is bearish, suggesting short‑term downside pressure. RSI is neutral at 49.6 and volume is on a decreasing trend, which may limit upward momentum. On the fundamentals side, the company reports a very low PE of 7.7 versus an industry average of 16.9 and a price‑to‑book of 1.69, while offering an eye‑catching dividend yield of 8.4%. However, profit margins are deeply negative (‑197%) and ROE is ‑19.8%, raising concerns about earnings sustainability despite a 94.5% revenue growth rate and a strong cash position of $734 M against $186 M of debt. The stock’s beta is low (≈0.18) and 30‑day volatility is moderate at 14.7%, but a historical max drawdown of ‑25% highlights downside risk. Overall, the valuation appears attractive on price metrics, yet the unsustainable dividend and ongoing losses temper enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering just above technical support
- Bearish MACD histogram and decreasing volume
- Negative earnings and questionable dividend sustainability
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong cash reserves relative to debt
- Rapid revenue growth despite current losses
- Low beta and moderate volatility offering defensive characteristics
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Potential earnings turnaround given revenue momentum
- Attractive price multiples versus industry peers
- Stable geographic footprint in the US with limited currency exposure
Key Metrics & Analysis
Financial Health
Revenue Growth94.50%
Profit Margin-196.94%
P/E Ratio7.7
ROE-19.82%
ROA-1.21%
P/B Ratio1.7
Industry P/E16.9
Technical Analysis
TrendBullish
RSI49.6
Support$20.00
Resistance$20.70
MA 20$20.36
MA 50$19.37
MA 200$17.78
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
GradeFair
TypeValue
Dividend Yield8.40%
Risk Assessment
Beta0.18
Volatility14.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.